Nicholas B. Griner, Ph.D. - Publications

Affiliations: 
2011 Molecular & Cellular Biology University of Massachusetts, Amherst, Amherst, MA 
Area:
Molecular Biology, Genetics, Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Majhi PD, Griner NB, Mayfield JA, Compton S, Kane JJ, Baptiste TA, Dunphy KA, Roberts AL, Schneider SS, Savage EM, Patel D, Blackburn AC, Maurus KJ, Wiesmüller L, Jerry DJ. Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome. Oncogene. PMID 34183771 DOI: 10.1038/s41388-021-01892-5  0.648
2020 Gagliardi A, Porter VL, Zong Z, Bowlby R, Titmuss E, Namirembe C, Griner NB, Petrello H, Bowen J, Chan SK, Culibrk L, Darragh TM, Stoler MH, Wright TC, Gesuwan P, et al. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. Nature Genetics. 52: 800-810. PMID 32747824 DOI: 10.1038/S41588-020-0673-7  0.359
2019 Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, et al. Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. PMID 30617194 DOI: 10.1182/Blood-2018-09-871418  0.405
2019 Kyi CW, Birriel PC, Davidsen TM, Ferguson ML, Gesuwan P, Griner NB, He Y, Jagu S, Tonsing-Carter E, Gerhard DS. Abstract 4341: NCI Office of Cancer Genomics: Promoting multidisciplinary research to translate findings into the clinic and advance precision oncology Cancer Research. 79: 4341-4341. DOI: 10.1158/1538-7445.Am2019-4341  0.388
2017 Grande BM, Gerhard DS, Griner NB, Casper C, Namirembe C, Omoding A, Orem J, Mbulaiteye SM, Mullighan CG, Sandlund JT, Alexander T, Choi JK, Abramson JS, Gross TG, Noy A, et al. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma Blood. 130: 39-39. DOI: 10.1182/Blood.V130.Suppl_1.39.39  0.397
2016 Gerhard DS, Grande B, Griner N, Casper C, Gerdts SE, Omoding A, Orem J, Mbulaiteye SM, Ogwang MD, Reynolds SJ, Bhatia K, Ayers L, Choi JK, Mullighan CG, Sandlund JT, et al. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction Blood. 128: 1760-1760. DOI: 10.1182/Blood.V128.22.1760.1760  0.434
2016 Jaber NL, Mazerik JN, Auvil JMG, Jagu S, Griner N, Ferguson M, Gerhard DS. Abstract 5293: NCI Office of Cancer Genomics: Generating publicly available data and resources for the advancement of precision medicine Cancer Research. 76: 5293-5293. DOI: 10.1158/1538-7445.Am2016-5293  0.339
2015 Griner NB, Young D, Chaudhary P, Mohamed AA, Huang W, Chen Y, Sreenath T, Dobi A, Petrovics G, Vishwanatha JK, Sesterhenn IA, Srivastava S, Tan SH. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. Molecular Cancer Research : McR. 13: 368-79. PMID 25344575 DOI: 10.1158/1541-7786.Mcr-14-0275-T  0.304
2014 Tan SH, Furusato B, Fang X, He F, Mohamed AA, Griner NB, Sood K, Saxena S, Katta S, Young D, Chen Y, Sreenath T, Petrovics G, Dobi A, McLeod DG, et al. Evaluation of ERG responsive proteome in prostate cancer. The Prostate. 74: 70-89. PMID 24115221 DOI: 10.1002/Pros.22731  0.312
2014 Wiesmüller L, Deniz M, Obermeier K, Böhringer M, Keimling M, Griner N, Jerry D. 8: Proffered Paper: Mono- and polygenic breast cancer susceptibility associates with error-prone homologous DNA double-strand break repair in mouse and man European Journal of Cancer. 50: S3-S4. DOI: 10.1016/S0959-8049(14)50008-1  0.653
2013 Böhringer M, Obermeier K, Griner N, Waldraff D, Dickinson E, Eirich K, Schindler D, Hagen M, Jerry DJ, Wiesmüller L. siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors. Oncogene. 32: 5458-70. PMID 23435420 DOI: 10.1038/Onc.2013.38  0.693
2011 Compton S, Kim C, Griner NB, Potluri P, Scheffler IE, Sen S, Jerry DJ, Schneider S, Yadava N. Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. The Journal of Biological Chemistry. 286: 20297-312. PMID 21502317 DOI: 10.1074/Jbc.M110.163063  0.556
2010 JOSEPH JERRY D, GRINER NB, TAO L. TUMOR SUPPRESSOR PATHWAYS AND CELLULAR ORIGINS OF BREAST CANCER: NEW COMPLEXITIES AND NEW HOPES Nano Life. 1: 1-16. DOI: 10.1142/S179398441000002X  0.666
2009 Griner NB, Compton SL, Dickinson ES, Boehringer M, Wiesmüller L, Jerry DJ. Abstract B56: Identification of genes involved in mammary tumor susceptibility and resistance in two strains of mice Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B56  0.676
2006 Hansen AB, Griner NB, Anderson JP, Kujoth GC, Prolla TA, Loeb LA, Glick E. Mitochondrial DNA integrity is not dependent on DNA polymerase-β activity Dna Repair. 5: 71-79. PMID 16165404 DOI: 10.1016/J.Dnarep.2005.07.009  0.386
Show low-probability matches.